Literature DB >> 10518526

Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3.

C Z Song1, X Tian, T D Gelehrter.   

Abstract

The transforming growth factor-beta (TGF-beta) family of cytokines and glucocorticoids regulate diverse biological processes through modulating the expression of target genes. Here we report that glucocorticoid receptor (GR) represses TGF-beta transcriptional activation of the type-1 plasminogen activator inhibitor (PAI-1) gene in a ligand-dependent manner. Similarly, GR represses TGF-beta activation of the TGF-beta responsive sequence containing Smad3/4-binding sites. Using mammalian two-hybrid assays, we demonstrate that GR inhibits transcriptional activation by both Smad3 and Smad4 C-terminal activation domains. Finally, we show that GR interacts with Smad3 both in vitro and in vivo. These results suggest a molecular basis for the cross-regulation between glucocorticoid and TGF-beta signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518526      PMCID: PMC18362          DOI: 10.1073/pnas.96.21.11776

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Recruitment of octamer transcription factors to DNA by glucocorticoid receptor.

Authors:  G G Préfontaine; M E Lemieux; W Giffin; C Schild-Poulter; L Pope; E LaCasse; P Walker; R J Haché
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 2.  New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?

Authors:  M Karin
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

Review 3.  Mads and Smads in TGF beta signalling.

Authors:  L Attisano; J L Wrana
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

4.  DNA binding of the glucocorticoid receptor is not essential for survival.

Authors:  H M Reichardt; K H Kaestner; J Tuckermann; O Kretz; O Wessely; R Bock; P Gass; W Schmid; P Herrlich; P Angel; G Schütz
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

5.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

6.  Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid.

Authors:  D J Chang; C Ji; K K Kim; S Casinghino; T L McCarthy; M Centrella
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.

Authors:  R Janknecht; N J Wells; T Hunter
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

8.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.

Authors:  X H Feng; Y Zhang; R Y Wu; R Derynck
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

9.  Human Smad3 and Smad4 are sequence-specific transcription activators.

Authors:  L Zawel; J L Dai; P Buckhaults; S Zhou; K W Kinzler; B Vogelstein; S E Kern
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.

Authors:  L I McKay; J A Cidlowski
Journal:  Mol Endocrinol       Date:  1998-01
View more
  47 in total

1.  Activin and glucocorticoids synergistically activate follicle-stimulating hormone beta-subunit gene expression in the immortalized LbetaT2 gonadotrope cell line.

Authors:  Shauna M McGillivray; Varykina G Thackray; Djurdjica Coss; Pamela L Mellon
Journal:  Endocrinology       Date:  2006-11-02       Impact factor: 4.736

2.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

3.  Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Authors:  Tracy Cherlet; Leigh C Murphy
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

4.  Computational Model of Secondary Palate Fusion and Disruption.

Authors:  M Shane Hutson; Maxwell C K Leung; Nancy C Baker; Richard M Spencer; Thomas B Knudsen
Journal:  Chem Res Toxicol       Date:  2017-01-20       Impact factor: 3.739

Review 5.  Microgravity and the implications for wound healing.

Authors:  Ramin Mostofizadeh Farahani; Luisa A DiPietro
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

Review 6.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

Review 7.  Immune regulation by glucocorticoids.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Nat Rev Immunol       Date:  2017-02-13       Impact factor: 53.106

8.  Mechanisms of in utero cortisol effects on the newborn heart revealed by transcriptomic modeling.

Authors:  Andrew Antolic; Mengchen Li; Elaine M Richards; Celia W Curtis; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

Review 9.  Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.

Authors:  Shisuo Du; Mary Helen Barcellos-Hoff
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 10.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.